{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:58:34Z","timestamp":1791460714573,"version":"4.3.4"},"reference-count":31,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Neutrophil recovery after bloodstream infection (BSI) in acute leukemia is clinically important, but evaluation is complicated by early death and recurrent infectious episodes. We assessed clinical, treatment-related, and microbiological factors associated with recovery while accounting for death as a competing event. Methods: This retrospective single-center cohort included 205 microbiologically documented BSI episodes in 101 adults with acute leukemia treated between 2020 and 2025. Neutrophil recovery was defined as an absolute neutrophil count &gt;500\/\u00b5L after BSI onset. The endpoint was evaluable in 186 episodes; 116 were followed by recovery and 70 by death before recovery. Recurrent episodes were retained and within-patient dependence was addressed by patient-level clustering in marginal Fine\u2013Gray regression. Results: In the fully adjusted model (177 episodes, 93 patients), G-CSF use was associated with a higher cumulative incidence of recovery (sHR 3.17, 95% CI 1.40\u20137.18; p = 0.006), as was consolidation versus induction (sHR 2.50, 95% CI 1.44\u20134.33; p = 0.001). Clinically relevant antimicrobial resistance was not independently associated with recovery (sHR 0.80, 95% CI 0.38\u20131.68; p = 0.558). A literal-first-BSI sensitivity analysis supported the overall clinical pattern. Conclusions: Neutrophil recovery after BSI was associated primarily with treatment and clinical context, while the crude adverse association with antimicrobial resistance was substantially attenuated after adjustment. These observational associations, particularly those involving G-CSF, should not be interpreted causally.<\/jats:p>","DOI":"10.3390\/cancers18193234","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:26:53Z","timestamp":1791458813000},"page":"3234","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Treatment-Related Factors Associated with Neutrophil Recovery After Bloodstream Infection in Acute Leukemia: A Competing-Risk Analysis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-6020","authenticated-orcid":false,"given":"Krzysztof","family":"Gawronski","sequence":"first","affiliation":[{"name":"Department of Hematology and Internal Medicine, Military Institute of Medicine\u2013National Research Institute, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Nadia","family":"Hussein","sequence":"additional","affiliation":[{"name":"Department of Hematology and Internal Medicine, Military Institute of Medicine\u2013National Research Institute, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Piotr","family":"Rzepecki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Internal Medicine, Military Institute of Medicine\u2013National Research Institute, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-8451","authenticated-orcid":false,"given":"Aneta","family":"Guzek","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnostics, Military Institute of Medicine\u2013National Research Institute, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e14236","DOI":"10.1111\/tid.14236","article-title":"Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies","volume":"26","author":"Stohs","year":"2024","journal-title":"Transpl. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10147-023-02465-0","article-title":"Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: A systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology","volume":"29","author":"Maeda","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gawronski, K., Hussein, N., Wo\u017aniak-Kosek, A., Zakrzewska, A., Rutkowska, E., Rzepecki, P., and Guzek, A. (2026). The impact of bacterial infections on delayed hematopoietic recovery in patients with acute leukemia after induction and consolidation therapy. J. Clin. Med., 15.","DOI":"10.3390\/jcm15083176"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gawronski, K., Hussein, N., Wo\u017aniak-Kosek, A., Rzepecki, P., and Guzek, A. (2026). NDM-producing Klebsiella pneumoniae bloodstream infection increases mortality and impairs hematopoietic recovery in acute leukemia. J. Clin. Med., 15.","DOI":"10.3390\/jcm15166259"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/biostatistics\/kxr032","article-title":"Competing risks regression for clustered data","volume":"13","author":"Zhou","year":"2012","journal-title":"Biostatistics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine\u2013Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Wei","year":"2022","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1007\/s00277-024-06069-0","article-title":"Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation","volume":"103","author":"McClellan","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41375-022-01786-9","article-title":"Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms","volume":"37","author":"Walti","year":"2023","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e24561","DOI":"10.1016\/j.heliyon.2024.e24561","article-title":"Spectrum of infections in different regimens of post-induction chemotherapy in acute myeloid leukemia (de-novo): A comparative retrospective study","volume":"10","author":"Majid","year":"2024","journal-title":"Heliyon"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199009273231304","article-title":"Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia","volume":"323","author":"Ohno","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_14","first-page":"7067","article-title":"Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)","volume":"30","author":"Link","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Garcia-Vidal, C., Cardozo-Espinola, C., Puerta-Alcalde, P., Marco, F., Tellez, A., Ag\u00fcero, D., Romero-Santana, F., D\u00edaz-Bey\u00e1, M., Gin\u00e9, E., and Morata, L. (2018). Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199531"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1007\/s00277-024-05866-x","article-title":"Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria","volume":"103","author":"Wang","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10238-023-01206-x","article-title":"Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: Epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years","volume":"23","author":"Peri","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wu, H., Li, M., Shou, C., Shi, F., Song, X., Hu, Q., Wang, Y., Chen, Y., and Tong, X. (2024). Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: A single centre retrospective study. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1390053"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/bmm-2023-0419","article-title":"Detection of infections by computerized capture of peaks in longitudinally measured C-reactive protein levels","volume":"17","author":"Garvik","year":"2023","journal-title":"Biomark. Med."},{"key":"ref_20","first-page":"e70024","article-title":"Plasma profiling of acute myeloid leukemia with fever- and infection-related complications during chemotherapy-induced neutropenia","volume":"7","author":"Kreft","year":"2024","journal-title":"Cancer Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/sim.8399","article-title":"A review of the use of time-varying covariates in the Fine\u2013Gray subdistribution hazard competing risk regression model","volume":"39","author":"Austin","year":"2020","journal-title":"Stat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.ijantimicag.2023.106806","article-title":"Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: Updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey","volume":"61","author":"Trecarichi","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103088","DOI":"10.1016\/j.jiph.2025.103088","article-title":"Risk factors and outcomes of bloodstream infection with multidrug-resistant bacteria in adult patients with acute leukemia","volume":"19","author":"Deng","year":"2026","journal-title":"J. Infect. Public Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wang, X., He, S., Chen, W., Li, Y., and Bu, J. (2026). Clinical characteristics and risk factor analysis of multidrug-resistant bacterial bloodstream infections in adult acute leukemia patients. Front. Microbiol., 17.","DOI":"10.3389\/fmicb.2026.1850927"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e14115","DOI":"10.1111\/tid.14115","article-title":"Effects of antimicrobial therapy duration and class on risk of antimicrobial-resistant Gram-negative bacillus bloodstream infection in patients with AML","volume":"25","author":"Huggins","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_27","first-page":"2359","article-title":"Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: An 11-year epidemiologic survey","volume":"30","author":"Facchin","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Davuto\u011flu, N.O., Pekta\u015f, G., and Pekta\u015f, M.B. (2026). Clinical and microbiological characteristics of polymicrobial bloodstream infections in hematologic malignancy patients: A cross-sectional study. BMC Infect. Dis., 26.","DOI":"10.1186\/s12879-026-12660-9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14787210.2023.2151440","article-title":"Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation","volume":"21","author":"Akhmedov","year":"2023","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Schmitt, S., Buchholz, A., and Ozga, A.-K. (2023). Systematic comparison of approaches to analyze clustered competing risks data. BMC Med. Res. Methodol., 23.","DOI":"10.1186\/s12874-023-01908-6"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:33:46Z","timestamp":1791459226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":31,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193234"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193234","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}